Melanoma protein patterns help predict immunotherapy response, survival
Protein patterns in melanoma tumors can predict how patients respond to immunotherapy and can be used to find promising biomarkers and drug targets, according to two new University of Pittsburgh studies.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.